Related Experiment Videos
Possible influence of changes in risk factors on cardiovascular morbidity and mortality in Israel: need for an
Insights
Mortality from ischemic heart disease (IHD) and cerebrovascular disease (CVD) declined significantly in Israel between 1978-82. Further data collection is recommended to understand the causes of this decline and plan future interventions.
Area of Science:
- Cardiovascular epidemiology
- Public health research
- Mortality statistics
Background:
- Significant declines in mortality from ischemic heart disease (IHD) and cerebrovascular disease (CVD) were observed in Israel from 1978 to 1982.
- The proportional decrease was substantial, affecting both males and females across both disease categories.
Purpose of the Study:
- To analyze the trends in IHD and CVD mortality in Israel during the specified period.
- To highlight the lack of data explaining the observed mortality decline.
- To emphasize the need for a national information system for future assessments.
Main Methods:
- Analysis of national mortality data for ischemic heart disease and cerebrovascular disease.
- Calculation of proportional mortality decline percentages for males and females.
- Review of existing data availability for explaining the observed trends.
Main Results:
- Mortality from IHD decreased by 27.5% in males and 34.4% in females.
- Mortality from CVD decreased by 37.0% in males and 40.4% in females.
- Limited data exists in Israel to explain these significant declines, questioning the role of major risk factor changes.
Conclusions:
- The observed decline in IHD and CVD mortality in Israel warrants further investigation.
- Development of a national-level information system for data collection and processing is a high priority.
- Future intervention programs should be guided by comprehensive morbidity and mortality data.
Abstract:
Mortality from ischemic heart disease (IHD) and cerebrovascular disease (CVD) has continued to fall in Israel during the period 1978-82. Proportionally, the fall has been 27.5% in males and 34.4% in females for IHD and 37.0 and 40.4% for CVD. There are few data available in Israel that can explain this decline, and it is doubtful whether it is due to any major attempt to change risk factor status. A top priority at this stage would seem to be the development of an information system (including data collection and processing) on a national level that will provide the opportunity for future assessment of the significance of change in such mortality. The need for future major intervention programs should be determined on the basis of such morbidity and mortality data.